J&J sees AI halving the time to generate drug development leads
Post Content
Business & Finance
Stay informed with expert takes on business strategy, investing, entrepreneurship, and global markets. CurioAtlas brings you articles that guide smarter decisions in finance and business growth.
A Kailera Therapeutics (KLRA) Insider Scooped up an Additional 500,000 Shares for $8.0 Million
Post Content
Gas prices are expected to keep rising in the absence of a US-Iran deal
Post Content
AI casts existential shadow over legacy software companies, Bridgewater CIOs warn
Post Content
Why Micron Stock Popped Again Today
Post Content
BofA raises Intellia Therapeutics stock price target on HAE data
Post Content
BTIG raises Oruka Therapeutics price target on trial results
Post Content
Spotify faces earnings test as pricing power meets Q1 seasonality
Post Content
FDM Group grants share awards to executives and managers
Post Content
Microsoft and OpenAI aren’t breaking up. But they’re not exclusive anymore.
The companies agreed to a deal that they said gives them more flexibility. As part of it, Microsoft will stop sharing its revenue.